The trademark ALGINOL was filed by Flen Health Group S.A., a corporation established under the laws of the Grand Duchy of Luxembourg (the "Applicant"). The application was published for oppositions on June 16, 2022, and received one opposition filed on September 6, 2022 by Brightwake Limited on Likelihood of confusion. the opponent was represented by SOCIETÀ ITALIANA BREVETTI S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 6, 2022
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
The Opposition with reference B 003178209 was refused according to Article 8(1)(b) EUTMR with decision issued on July 14, 2024 by the EUIPO.